Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years-Reference-Cited by-同舟云学术

Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years

Published:2019-10-22 Issue:20 Volume:3 Page:3070-3079
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Sheth Vipul Sharad¹,Potter Victoria¹,Gandhi Shreyans A.¹²,Kulasekararaj Austin Gladston¹,de Lavallade Hugues¹²,Muus Petra¹,Pagliuca Antonio¹²,Rice Carmel F. M.¹,Mehra Varun¹^ORCID,Grimaldi Francesco²³,Inam Shafqat¹,Barber Linda D.²,Mufti Ghulam J.¹²,Marsh Judith C.¹²

Affiliation:

1. Department of Haematological Medicine, King’s College Hospital, London, United Kingdom;

2. Department of Haematological Medicine, King’s College London, London, United Kingdom; and

3. Department of Hematology, Federico III University of Naples, Naples, Italy

Abstract

Key Points GRFS is similar between older and younger patients using FCC conditioning but comorbidities impact on outcome of SAA HSCT. Immunomodulatory B lymphocytes potentially contribute to control of alloreactivity and low GVHD after FCC HSCT.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/3/20/3070/1502763/advancesadv2019000480.pdf

Reference46 articles.

1. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia;Tichelli;Ann Intern Med,1999

2. Treatment of aplastic anaemia in elderly patients aged >60 years;Tichelli;Bone Marrow Transplant,2013

3. Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy;Kao;Br J Haematol,2008

4. Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study;Vaht;Eur J Haematol,2018

5. Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011;Vaht;Haematologica,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aplasies médullaires sévères acquises dans les pays émergents : prise en charge dès l’indication de l’allogreffe de cellules souches hématopoïétiques jusqu’au suivi postgreffe (SFGM-TC);Bulletin du Cancer;2024-09

2. The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults;Frontiers in Immunology;2024-04-05

3. Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline;British Journal of Haematology;2024-01-21

4. Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.;Haematologica;2023-03-23

5. Allogeneic bone marrow transplantation for aplastic anemia;International Journal of Hematology;2022-12-28